(Q39321170)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Rui Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kristen Evaul

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kamalesh K Sharma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kai-Hsiung Chang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jiayan Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Richard J Auchus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Nima Sharifi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

1 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

3571-3579

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

10.1158/1078-0432.CCR-12-0908

6 February 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22753664%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference